Publications by authors named "Jay Saoud"

Claim this Profile
E
Efficacy and Safety of Seltorexant in Insomnia Disorder: A Randomized Clinical Trial.
Sofie Mesens, Andrew D Krystal, Rama Melkote, Haiyan Xu, Gahan Pandina, Jay B Saoud

JAMA Psychiatry· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Network intervention analysis indicates that roluperidone achieves its effect on negative symptoms of schizophrenia by targeting avolition.
Sydney H James, Anthony O Ahmed, Philip D Harvey, Jay B Saoud, Michael Davidson

Eur Neuropsychopharmacol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of prominent and predominant negative symptoms across different criteria for negative symptom severity and minimal positive symptoms: A comparison of different criteria.
Philip D Harvey, Michael Davidson, Jay B Saoud, Ramana Kuchibhatla, Raeanne C Moore

Schizophr Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Somno-Art Software identifies pathology-induced changes in sleep parameters similarly to polysomnography.
Laurie Thiesse, Luc Staner, Patrice Bourgin, Henri Comtet, Gil Fuchs, Jay B Saoud

PLoS One· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term effects of Roluperidone on negative symptoms of schizophrenia.
Jonathan Rabinowitz, Corinne Staner, Jay Saoud, Mark Weiser, Ramana Kuchibhatla

Schizophr Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of Somno-Art Software compared to polysomnography interscorer variability: A multi-center study.
Laurie Thiesse, Luc Staner, Gil Fuchs, Débora Kirscher, Valentin Dehouck, Jay B Saoud

Sleep Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Roluperidone for the Treatment of Negative Symptoms of Schizophrenia.
Michael Davidson, Jay Saoud, Corinne Staner, Nadine Noel, Sandra Werner

Schizophr Bull· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of Somno-Art Software, a novel approach of sleep staging, compared with polysomnography in disturbed sleep profiles.
Laurie Thiesse, Luc Staner, Patrice Bourgin, Thomas Roth, Gil Fuchs, Jay B Saoud

Sleep Adv· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Network Analysis Indicates That Avolition Is the Most Central Domain for the Successful Treatment of Negative Symptoms: Evidence From the Roluperidone Randomized Clinical Trial.
Gregory P Strauss, Farnaz Zamani Esfahlani, Hiroki Sayama, Brian Kirkpatrick, Mark G Opler, Jay B Saoud

Schizophr Bull· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Roluperidone (MIN-101) on two dimensions of the negative symptoms factor score: Reduced emotional experience and reduced emotional expression.
Philip D Harvey, Jay B Saoud, Remy Luthringer, Svetlana Moroz, Yuliya Blazhevych

Schizophr Res· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do Patterns of Instability or Severity of Psychopathology During Screening Predict Relapse in Schizophrenic Outpatient Subjects with Moderate to Severe Negative Symptoms Assigned to Placebo?
David G Daniel, Alan Kott, Jay Saoud, Remy Luthringer, Vadym Rud

Innov Clin Neurosci· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personal and social adjustment effects of roluperidone in patients with schizophrenia and negative symptoms: Results from an exploratory outcome of a randomized placebo-controlled trial.
Jonathan Rabinowitz, Stefan Badescu, Pavel Palamarchuk, Viktor Filyk, Anatolii Voloshchuk, Jay Saoud

Schizophr Res· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive Effects of MIN-101 in Patients With Schizophrenia and Negative Symptoms: Results From a Randomized Controlled Trial.
Richard S E Keefe, Philip D Harvey, Anzalee Khan, Jay B Saoud, Corinne Staner

J Clin Psychiatry· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The brief negative symptom scale (BNSS): Sensitivity to treatment effects.
Brian Kirkpatrick, Jay B Saoud, Gregory P Strauss, Anthony O Ahmed, Kazunori Tatsumi

Schizophr Res· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of MIN-101: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial of a New Drug in Development for the Treatment of Negative Symptoms in Schizophrenia.
Michael Davidson, Jay Saoud, Corinne Staner, Nadine Noel, Elisabeth Luthringer

Am J Psychiatry· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing sleep architecture and continuity measures through the analysis of heart rate and wrist movement recordings in healthy subjects: comparison with results based on polysomnography.
Alain Muzet, Sandra Werner, Gil Fuchs, Thomas Roth, Jay B Saoud

Sleep Med· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AVI-7288 for Marburg Virus in Nonhuman Primates and Humans.
Alison E Heald, Jay S Charleston, Patrick L Iversen, Travis K Warren, Jay B Saoud

N Engl J Med· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and pharmacokinetic profiles of phosphorodiamidate morpholino oligomers with activity against ebola virus and marburg virus: results of two single-ascending-dose studies.
Alison E Heald, Patrick L Iversen, Jay B Saoud, Peter Sazani, Jay S Charleston

Antimicrob Agents Chemother· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eteplirsen for the treatment of Duchenne muscular dystrophy.
Jerry R Mendell, Louise R Rodino-Klapac, Zarife Sahenk, Kandice Roush, Loren Bird, Jay B Saoud

Ann Neurol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis